B. Braun Dextrose Injection 70% Recall
DEXTROSE INJECTION USP, 70%, 2000 mL bags, Rx only, Sterile, B. Braun Medical Inc., Bethlehem, PA 18018-3524, USA, NDC: 0264-7387-50.
Updated April 2, 2026
B. Braun Medical is recalling Dextrose Injection USP 70% in 2000 mL bags due to a lack of sterility assurance and potential leakage from the diaphragm port. These are prescription sterile intravenous medications for hospital and clinical use only.
Is the B BRAUN MEDICAL INC recalled? Yes. This product was recalled by FDA on April 2, 2026. Details below.
What is recalled
Dextrose Injection USP, 70%, 2000 mL bags, Rx only, Sterile. Manufacturer: B. Braun Medical Inc., Bethlehem, PA 18018-3524. NDC: 0264-7387-50.
Am I affected
You are affected if you are a hospital, clinic, or healthcare facility that received Dextrose Injection USP 70% in 2000 mL bags (NDC 0264-7387-50) from B. Braun Medical.
What to do right now
If you are a healthcare provider, stop using this product immediately and contact B. Braun Medical to report possession and receive instructions for safe return or disposal. Do not use any affected bags for patient infusion.
The hazard
Lack of Assurance of Sterility; potential for leakage from the diaphragm port once the foil is removed.
Brands affected
- Source
- FDA
- Category
- Drugs & Medications
- Recall ID
- fda-D-0496-2026
- Classification
- Class II
- Recalled
- April 2, 2026
Get free recall alerts
New Drugs & Medications recalls, the moment they post.
Free forever. Unsubscribe anytime. We never sell your data.
More Drugs & Medications recalls
IntegraDose Fentanyl Citrate Injection Recall
IntegraDose Compounding Services is recalling fentanyl citrate sterile injection (2,500 mcg/50mL) because the doses are subpotent, meaning they contain less …
IntegraDose Compounding Services LLC
Safecor Atomoxetine 10mg Recall
Safecor Health is recalling Atomoxetine Capsules labeled as 10 mg because some capsules actually contain 25 mg due to a labeling error. Taking the wrong dose of …
Safecor Health, LLC
Zydus Erythromycin 500 mg Tablets Recall
Zydus Pharmaceuticals is recalling Erythromycin 500 mg tablets because they contain higher-than-safe levels of a potentially harmful chemical. If you take this …
Zydus Pharmaceuticals (USA) Inc